Latest Breaking News On - Phasei new approaches - Page 1 : comparemela.com

A Phase I study has shown significant promise in treating newly diagnosed ALK-driven high-risk neuroblastoma in paediatric patients.

United statesYaelp mossKelly goldsmithEmory university school of medicineCancer center at children hospital of philadelphiaDrug administrationNational cancer instituteTherapy programChildren oncology groupBlood disorders centerEuropean phasePhasei new approachesNeuroblastoma therapyDevelopmental therapeutics programWinship cancer instituteEmory university